$CBIS Recently, Cannabis Science launched its initial test batch of suppositories to trial patients, and will be watching the results closely in addition to proactively seeking patient feedback. This will help optimize the drug’s formulation and further dial in the target market. Due to the suppository market not being as “glamorous” as the ingested or smoked cannabis markets, Cannabis Science expects to address a significant demand from consumers who are unable to ingest, smoke, or vape their drugs. There is less competition on the suppository side of the market, which creates tremendous opportunity. Additionally, cannabis-based suppositories have proven to be 50-70% more efficient and predictable than other forms of cannabis drug consumption.

http://www.mmjobserver.com/cannabis-science-i...ent/28638/